Stepping down therapy for well-controlled mild asthma: an experience from University Medical Center at Ho Chi Minh City
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Asia Pacific Allergy
- Vol. 11 (1)
Abstract
Background: Stepping down treatment for well-controlled mild asthma is challenging to clinicians. The step-down strategy using regularly-intermittent low-dose inhaled corticosteroid has been applied at the University Medical Center (UMC) of Ho Chi Minh City, called as “UMC” approach. Objective: This study aimed to evaluate the efficiency of UMC step-down strategy in well- controlled mild asthma. Methods: A real-world retrospective descriptive study was conducted at UMC from 2009 to 2018. All asthmatic patients (age ≥ 12) who received step-down therapy using this UMC approach were evaluated. Results: Among 2,072 asthma patients to be treated with UMC step-down strategy, only 112 subjects were eligible. The median age was 38.5 years and female was 62.5%. Most patients at their initial presentation were indicated step 4 treatment (87.5%). The controller medications before initiation of UMC treatment included fluticasone propionate 125 μg once-daily, salmeterol/fluticasone propionate 25/125 μg once-daily, and formoterol/budesonide 4.5/160 μg once-daily. After being treated with the UMC approach, the rates of well-controlled asthma ranged from 67.6% to 91.1%. During 1 year with UMC treatment, pulmonary function remained stable and only 7 subjects (6.3%) developed exacerbation. Conclusion: The UMC step-down treatment for well-controlled mild asthma was relatively efficient in maintaining asthma control, stabilization of pulmonary function, and reducing risk of severe exacerbation.Keywords
This publication has 12 references indexed in Scilit:
- It is time to change the way we manage mild asthma: an update in GINA 2019Respiratory Research, 2019
- The Asthma Controller Step-down YardstickAnnals of Allergy, Asthma & Immunology, 2019
- As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild AsthmaNew England Journal of Medicine, 2018
- Inhaled Combined Budesonide–Formoterol as Needed in Mild AsthmaNew England Journal of Medicine, 2018
- Patients’ beliefs and behaviors related to treatment adherence in patients with asthma requiring maintenance treatment in AsiaJournal of Asthma, 2014
- The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trialsJournal of Allergy and Clinical Immunology, 2013
- Randomized Comparison of Strategies for Reducing Treatment in Mild Persistent AsthmaNew England Journal of Medicine, 2007
- Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild AsthmaNew England Journal of Medicine, 2007
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Perception of the Role and Potential Side Effects of Inhaled Corticosteroids Among Asthmatic PatientsChest, 1998